Page last updated: 2024-10-28

hydroxychloroquine and Hematologic Diseases

hydroxychloroquine has been researched along with Hematologic Diseases in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kuraitis, D1
Murina, A1
Tanenbaum, L1
Tuffanelli, DL1

Reviews

1 review available for hydroxychloroquine and Hematologic Diseases

ArticleYear
Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.
    Archives of dermatology, 1980, Volume: 116, Issue:5

    Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Chloroquine; DNA; Eye Diseases; Female; Hemat

1980

Other Studies

1 other study available for hydroxychloroquine and Hematologic Diseases

ArticleYear
Facts, not Fear: Safety of Hydroxychloroquine.
    The American journal of the medical sciences, 2020, Volume: 360, Issue:2

    Topics: Acute Generalized Exanthematous Pustulosis; Agranulocytosis; Anemia, Aplastic; Antirheumatic Agents;

2020